Wedbush Securities’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $203K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $307K | Buy |
|
|||||
|
2024
Q1 | $362K | Buy |
|
|||||
|
2023
Q4 | $260K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $211K | Sell |
|
|||||
|
2023
Q1 | $224K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $370K | Sell |
|
|||||
|
2022
Q2 | $529K | Hold |
|
|||||
|
2022
Q1 | $546K | Sell |
|
|||||
|
2021
Q4 | $698K | Buy |
|
|||||
|
2021
Q3 | $928K | Sell |
|
|||||
|
2021
Q2 | $1.39M | Sell |
|
|||||
|
2021
Q1 | $1.05M | Buy |
|